Impact of targeted therapies withPDE5 inhibitors, endothelin receptor antagonists and sotatercept on functional tricuspid regurgitation in pulmonary arterial hypertension

30 August 2026 (17:36 - 17:48)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy of pulmonary arterial hypertension Pulmonary Hypertension ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology